Status:
COMPLETED
Para-Aortic Lymph Nodal Staging & Evaluation of Treatment Outcome by 18F FDG-PET in Advanced Cancer Cervix
Lead Sponsor:
Tata Memorial Hospital
Conditions:
Cancer of Cervix
Eligibility:
FEMALE
18-65 years
Brief Summary
18F-fluorodeoxyglucose Positron Emission Tomography (FDG-PET) Imaging has been extensively used in the evaluation of various malignancies and is rapidly being recognized as a mandatory investigations....
Detailed Description
BACKGROUND AND RATIONALE: Carcinoma Cervix is the commonest malignancy and a leading cause of cancer mortality seen in Indian women. At Tata Memorial Hospital, Carcinoma Cervix constitutes approximat...
Eligibility Criteria
Inclusion
- Histologically proven squamous carcinoma or adenocarcinoma of cervix
- Performance index WHO grade 0 or 1
- Patients below 65 years of age
- FIGO Stage IIB / IIIB
- Normal ECG and Cardiovascular system
- Normal hematological parameters
- Normal renal and liver function tests
- Normal Blood Sugar levels / Controlled Diabetes
Exclusion
- Co-morbid conditions like medical renal disease
- Past History of Phobia for MRI Examination
- Medical or Psychological condition that would preclude Investigations / Treatment
- H/o Previous treatment / Pregnancy
- Patient unreliable for treatment completion and follow-up Investigations.
Key Trial Info
Start Date :
September 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2018
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00193752
Start Date
September 1 2005
End Date
January 1 2018
Last Update
January 23 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tata Memorial Hospital
Mumbai, Maharashtra, India, 400 012